ELITE PHARMACEUTICALS INC /NV/ 4
4 · ELITE PHARMACEUTICALS INC /NV/ · Filed Sep 12, 2014
Insider Transaction Report
Form 4
TREPPEL JERRY
DirectorChairman & CEO
Transactions
- Conversion
Common Stock
2014-09-10+6,060,000→ 9,266,558 total - Conversion
Series I Convertible Preferred Shares
2014-09-10$100000.00/sh−4.242$424,200→ 0 totalExercise: $0.07From: 2014-02-07→ Common Stock (6,060,000 underlying)
Footnotes (2)
- [F1]These preferred shares are convertible into shares of common stock at the rate of 1,428,571.43 shares common stock for each whole share of preferred stock.
- [F2]N/A